OPYL LIMITED Financials Opyl Limited Australian S.E.
Equities
OPL
AU0000062838
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - AUD | -.--% |
|
-.--% | -.--% |
| Apr. 23 | Opyl to Divest Opin Business | MT |
| Mar. 22 | Opyl Receives Offer for Patient Recruitment Business | MT |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6.106 | 1.559 | 2.629 | 9.77 | 2.551 | 1.759 |
| Enterprise Value (EV) 1 | 4.542 | 1.64 | 1.829 | 7.454 | 1.765 | 1.606 |
| P/E ratio | -1.49 x | -0.55 x | -3.46 x | -6.36 x | -1.23 x | -1.02 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 14.8 x | 1.68 x | 4.23 x | 12.7 x | 2.83 x | 2.85 x |
| EV / Revenue | 11 x | 1.77 x | 2.95 x | 9.71 x | 1.96 x | 2.6 x |
| EV / EBITDA | -1.51 x | -0.74 x | -2.05 x | -5.63 x | -0.86 x | -0.95 x |
| EV / FCF | -2.77 x | -1.31 x | -2.44 x | -11.8 x | -2.33 x | -1.9 x |
| FCF Yield | -36% | -76.4% | -40.9% | -8.47% | -42.9% | -52.5% |
| Price to Book | 4.2 x | -3.87 x | 4.45 x | 4.47 x | 9.55 x | -4.36 x |
| Nbr of stocks (in thousands) | 12,211 | 15,589 | 30,216 | 54,279 | 54,279 | 79,959 |
| Reference price 2 | 0.5000 | 0.1000 | 0.0870 | 0.1800 | 0.0470 | 0.0220 |
| Announcement Date | 8/31/18 | 9/1/19 | 8/27/20 | 8/26/21 | 8/30/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.4136 | 0.927 | 0.6208 | 0.7677 | 0.9024 | 0.6179 |
| EBITDA 1 | -3.006 | -2.229 | -0.8927 | -1.323 | -2.058 | -1.698 |
| EBIT 1 | -3.041 | -2.255 | -0.8936 | -1.328 | -2.083 | -1.725 |
| Operating Margin | -735.22% | -243.29% | -143.95% | -172.92% | -230.88% | -279.09% |
| Earnings before Tax (EBT) 1 | -3.036 | -3.105 | -0.8834 | -1.143 | -2.086 | -1.726 |
| Net income 1 | -3.036 | -3.105 | -0.9258 | -1.143 | -2.086 | -1.726 |
| Net margin | -734.02% | -334.95% | -149.14% | -148.94% | -231.11% | -279.38% |
| EPS 2 | -0.3349 | -0.1833 | -0.0252 | -0.0283 | -0.0384 | -0.0216 |
| Free Cash Flow 1 | -1.637 | -1.254 | -0.748 | -0.6317 | -0.7568 | -0.8439 |
| FCF margin | -395.88% | -135.22% | -120.49% | -82.28% | -83.86% | -136.57% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/31/18 | 9/1/19 | 8/27/20 | 8/26/21 | 8/30/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 0.08 | - | - | - | - |
| Net Cash position 1 | 1.56 | - | 0.8 | 2.32 | 0.79 | 0.15 |
| Leverage (Debt/EBITDA) | - | -0.0364 x | - | - | - | - |
| Free Cash Flow 1 | -1.64 | -1.25 | -0.75 | -0.63 | -0.76 | -0.84 |
| ROE (net income / shareholders' equity) | -374% | -626% | -585% | -78.7% | -170% | 2,528% |
| ROA (Net income/ Total Assets) | -143% | -119% | -88.2% | -48.3% | -74.8% | -128% |
| Assets 1 | 2.127 | 2.604 | 1.049 | 2.369 | 2.788 | 1.352 |
| Book Value Per Share 2 | 0.1200 | -0.0300 | 0.0200 | 0.0400 | 0 | -0.0100 |
| Cash Flow per Share 2 | 0.1300 | 0.0100 | 0.0200 | 0.0400 | 0.0100 | 0.0100 |
| Capex | - | - | 0.01 | 0.01 | 0.01 | 0 |
| Capex / Sales | - | - | 1.51% | 1.89% | 1.15% | 0.36% |
| Announcement Date | 8/31/18 | 9/1/19 | 8/27/20 | 8/26/21 | 8/30/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.17B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -24.12% | 857M |
- Stock Market
- Equities
- OPL Stock
- OPL Stock
- Financials Opyl Limited
